SUMMARY Evaluation of the therapeutic potential of RNAi for HIV infection has been hampered by the challenges of siRNA delivery and lack of suitable animal models. Using a novel delivery method in humanized mice, we show that siRNA treatment can dramatically suppress HIV infection. A CD7-specific single-chain antibody was conjugated to oligo-9-arginine peptide (scFvCD7-9R) for T cell-specific siRNA delivery in NOD/SCIDIL2rγ−/− mice reconstituted with human lymphocytes (Hu-PBL) or CD34+ hematopoietic stem cells (Hu-HSC). In HIV-infected Hu-PBL mice, treatment with anti-CCR5 and antiviral siRNAs complexed to scFvCD7-9R controlled viral replication and prevented the disease-associated CD4 T cell loss. This treatment also suppressed endogenous virus and restored CD4 T cell counts in mice reconstituted with HIV+ PBMC. Moreover, scFvCD7-9R could deliver antiviral siRNAs to naïve T cells in Hu-HSC mice and effectively suppress viremia in infected mice. Thus, siRNA therapy for HIV infection appears to be feasible in a preclinical animal model.

To migrate efficiently through the interstitium, dendritic cells (DCs) constantly adapt their shape to the given structure of the extracellular matrix and follow the path of least resistance. It is known that this amoeboid migration of DCs requires Cdc42, yet the upstream regulators critical for localization and activation of Cdc42 remain to be determined. Mutations of DOCK8, a member of the atypical guanine nucleotide exchange factor family, causes combined immunodeficiency in humans.In the present study, we show that DOCK8 is a Cdc42-specific guanine nucleotide exchange factor that is critical for interstitial DC migration. By generating the knockout mice, we found that in the absence of DOCK8, DCs failed to accumulate in the lymph node parenchyma for T-cell priming. Although DOCK8-deficient DCs migrated normally on 2-dimensional surfaces, DOCK8 was required for DCs to crawl within 3-dimensional fibrillar networks and to transmigrate through the subcapsular sinus floor. This function of DOCK8 depended on the DHR-2 domain mediating Cdc42 activation. DOCK8 deficiency did not affect global Cdc42 activity. However, Cdc42 activation at the leading edge membrane was impaired in DOCK8-deficient DCs, resulting in a severe defect in amoeboid polarization and migration. Therefore, DOCK8 regulates interstitial DC migration by controlling Cdc42 activity spatially. (Blood. 2012; 119(19):4451-4461) IntroductionDendritic cells (DCs) are specialized APCs that play a critical role in the initiation of adaptive immune responses. 1 After antigen exposure, DCs phagocytose antigens in peripheral tissues and migrate via the afferent lymphatic vessels into the draining lymph nodes (LNs) to stimulate T cells. 2,3 During this process, DCs switch their sessile sampling behavior to a highly migratory one, which is characterized by the acquisition of a polarized morphology and increased expression of the chemokine receptor CCR7. Whereas CCR7 signals guide DCs to the LN parenchyma, 4 DCs must pass through a 3-dimensional (3D) interstitial space composed of fibrillar extracellular matrix (ECM) before reaching their destination. To perform this task efficiently, DCs constantly adapt their shape to the given structure of the interstitial ECM and follow the path of least resistance. 5 This amoeboid migration of DCs occurs independently of adhesion to specific substrates and ECM degradation, 6,7 yet its regulatory mechanisms are poorly understood.Cdc42 is a member of the Rho family of small GTPases that function as molecular "switches" by cycling between GDP-bound inactive states and GTP-bound active states. 8 Cdc42 exists in the cytosol in the GDP-bound form and is recruited to membranes, where its GDP is exchanged for GTP because of the action of one or more guanine nucleotide exchange factors (GEFs). Once activated, Cdc42 binds to multiple effector molecules and regulates various cellular functions. Cdc42 is known to act as a master regulator of cell polarity in eukaryotic organisms ranging from yeasts to humans. 8 In addition, a recent stu...

Thymocyte trafficking has an important role in thymic selection. Here we show that the Hippo homologue mst1 is required for thymocyte migration and antigen recognition by LFA-1 and ICAm-1 within the medulla. using two-photon imaging of thymic tissues, we found that highly motile mature thymocytes arrest and are activated in the vicinity of rare populations of Aire + ICAm-1 hi medullary thymic epithelia in a negatively selecting environment. notably, mst1 deficiency or blocking the cell adhesion molecules LFA-1 and ICAm-1 results in inefficient migration and antigen recognition of CD4 + thymocytes within the medulla. Consistent with these defects, thymocyte selection is impaired in Mst1 − / − mice, which display T cell-dependent inflammatory infiltrates in multiple organs and develop autoantibodies. our results suggest that mst1 has a key role in regulating thymocyte self-antigen recognition in the medulla.